TWD
AUPH icon

True Wealth Design’s Aurinia Pharmaceuticals AUPH Stock Holding History

True Wealth Design’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$162 Buy
+10
New +$160 ﹤0.01% 2380
2025
Q2 		– Sell
-356
Closed -$2.86K – 2588
2025
Q1 		$2.86K Buy
356
+274
+334% +$2.22K ﹤0.01% 882
2024
Q4 		$737 Sell
82
-386
-82% -$3.15K ﹤0.01% 1016
2024
Q3 		$3.43K Buy
+468
New +$2.9K ﹤0.01% 661

Other funds holding AUPH

JWS
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
AIM
Acropolis Investment Management St. Louis, Missouri $2.49B AUM 10.8% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

True Wealth Design's AUPH Position: Q3 2026 in Review

True Wealth Design opened a new position in Aurinia Pharmaceuticals (AUPH) in Q3 2026: 10 shares worth $162. The stake represents ﹤0.01% of the portfolio and ranks #2380 among its holdings. This is a return to the name: True Wealth Design previously reported a position in AUPH as recently as Q1 2025.

True Wealth Design first reported a position in AUPH in Q3 2024 and has held it in 4 quarters since. The position peaked at $3.43K in Q3 2024. 7 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.

  • True Wealth Design held 10 shares of Aurinia Pharmaceuticals worth $162 as of Q3 2026.
  • Aurinia Pharmaceuticals was a new True Wealth Design position in Q3 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #2380 holding.
  • True Wealth Design first reported a position in Aurinia Pharmaceuticals in Q3 2024 and has held it in 4 quarters since.
  • True Wealth Design's Aurinia Pharmaceuticals position peaked at $3.43K in Q3 2024.
  • 7 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.